By using R6/2 HD transgenic mice, Valenza et al. demonstrated that disruptions in lipid biosynthesis are, at least partially, attributed to a mutant Htt-dependent reduction in SREBP activity [107]. The gene discussed is HTT; the disease is Huntington disease.